PLUVICTO AND LUTATHERA
$4,299,447
| Recipient | NOVARTIS PHARMACEUTICALS CORPORATION UEI NG61ZA8TADW3 |
|---|---|
| Award ID | 36C26226N0112 |
| Award amount | $4,299,447 |
| Award type | DELIVERY ORDER |
| Awarding agency | Department of Veterans Affairs — Department of Veterans Affairs |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Nov 1, 2025 |
| End date | Oct 31, 2026 |
| Place of performance | EAST HANOVER, NJ |
| Record updated | Sep 15, 2026 |
View the official award record
More awards won by NOVARTIS PHARMACEUTICALS CORPORATION
ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF
Department of Health and Human Services · $16,334,775 · Sep 14, 2017
CLIN 2001AA AND CLIN 2001AB
Department of Defense · $5,369,485 · Oct 1, 2026
PLUVICTO
Department of Veterans Affairs · $4,732,608 · Feb 24, 2026
LU177 - PLUVICTO/LUTATHERA
Department of Veterans Affairs · $4,162,659 · Feb 7, 2026
PLUVICTO NDC: 69488-0010-61
Department of Veterans Affairs · $4,115,311 · Oct 1, 2026
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids